KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Hims & Hers Health (HIMS) over the last 6 years, with Q3 2025 value amounting to 1.97%.

  • Hims & Hers Health's EBIT Margin fell 36000.0% to 1.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.2%, marking a year-over-year increase of 17500.0%. This contributed to the annual value of 4.19% for FY2024, which is 75700.0% up from last year.
  • Latest data reveals that Hims & Hers Health reported EBIT Margin of 1.97% as of Q3 2025, which was down 36000.0% from 4.9% recorded in Q2 2025.
  • Over the past 5 years, Hims & Hers Health's EBIT Margin peaked at 9.88% during Q1 2025, and registered a low of 92.54% during Q1 2021.
  • In the last 5 years, Hims & Hers Health's EBIT Margin had a median value of 4.44% in 2023 and averaged 11.59%.
  • As far as peak fluctuations go, Hims & Hers Health's EBIT Margin plummeted by -718500bps in 2021, and later skyrocketed by 758400bps in 2022.
  • Quarter analysis of 5 years shows Hims & Hers Health's EBIT Margin stood at 25.46% in 2021, then skyrocketed by 73bps to 6.94% in 2022, then soared by 98bps to 0.16% in 2023, then surged by 2483bps to 3.86% in 2024, then tumbled by -49bps to 1.97% in 2025.
  • Its EBIT Margin stands at 1.97% for Q3 2025, versus 4.9% for Q2 2025 and 9.88% for Q1 2025.